StockClub

VRCA

VRCAVerrica Pharmaceuticals Inc.$ --
Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc.

VRCA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
5M USD
YoY +1380.2%
Operating Income
-7M USD
YoY +39.1%
Net Income
-8M USD
YoY +50.2%
EPS
-0.64$
YoY +73.4%

Revenue

$35.6M
FY2024 Q1$3.8M
$3.8M
Q1
FY2024 Q2$9M
$9M
Q2
FY2024 Q3$7.2M
$7.2M
Q3
FY2024 Q4$7.6M
$7.6M
Q4
FY2025 Q1$3.4M
$3.4M
Q1
FY2025 Q2$16.1M
$16.1M
Q2
FY2025 Q3$30.5M
$30.5M
Q3
FY2025 Q4$35.6M
$35.6M
Q4
Actual
+$28M (+370.2%)

Net Income

$-17.9M
FY2024 Q1$-20.3M
$-20.3M
Q1
FY2024 Q2$-37.5M
$-37.5M
Q2
FY2024 Q3$-60.4M
$-60.4M
Q3
FY2024 Q4$-76.6M
$-76.6M
Q4
FY2025 Q1$-9.7M
$-9.7M
Q1
FY2025 Q2$-9.5M
$-9.5M
Q2
FY2025 Q3$-9.8M
$-9.8M
Q3
FY2025 Q4$-17.9M
$-17.9M
Q4
Actual
+$58.7M (+76.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021IN-LINE
Actual:$12M
Est:$12M
FY2021IN-LINE
$12M
FY2022BEAT
Actual:$9M
Est:$7.4M
FY2022BEAT
$9M
FY2023MISS
Actual:$5.1M
Est:$8.9M
FY2023MISS
$5.1M
FY2024MISS
Actual:$7.6M
Est:$8.3M
FY2024MISS
$7.6M
FY2025BEAT
Actual:$35.6M
Est:$35M
FY2025BEAT
$35.6M

Analyst Estimates